Because we don't know the reasoning behind their decision to sell I'm not sure we could classify it a bearish move, plus I certainly wouldn't entangle the two different positions (copaxone and stock). On one hand they paid somewhere around $15 ten years ago so selling now isn't a profitable move.
Hell, maybe they want to be a normal Momenta Stockholder.